Abhai Llc Company Profile
✉ Email this page to a colleague
What is the competitive landscape for ABHAI LLC
ABHAI LLC has sixteen approved drugs.
Drugs and US Patents for Abhai Llc
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Abhai Llc | DESMOPRESSIN ACETATE | desmopressin acetate | TABLET;ORAL | 210371-001 | Jan 28, 2019 | AB | RX | No | No | ⤷ Start Trial | ⤷ Start Trial | ||||
| Abhai Llc | DEXMETHYLPHENIDATE HYDROCHLORIDE | dexmethylphenidate hydrochloride | TABLET;ORAL | 206931-002 | Dec 4, 2015 | AB | RX | No | No | ⤷ Start Trial | ⤷ Start Trial | ||||
| Abhai Llc | METHYLPHENIDATE HYDROCHLORIDE | methylphenidate hydrochloride | TABLET, EXTENDED RELEASE;ORAL | 207488-002 | Jun 9, 2015 | AB | RX | No | Yes | ⤷ Start Trial | ⤷ Start Trial | ||||
| Abhai Llc | OXYCODONE HYDROCHLORIDE | oxycodone hydrochloride | SOLUTION;ORAL | 208593-002 | Jul 21, 2017 | AA | RX | No | No | ⤷ Start Trial | ⤷ Start Trial | ||||
| Abhai Llc | URSODIOL | ursodiol | CAPSULE;ORAL | 210707-001 | May 17, 2018 | AB | RX | No | No | ⤷ Start Trial | ⤷ Start Trial | ||||
| Abhai Llc | OXYBUTYNIN CHLORIDE | oxybutynin chloride | TABLET;ORAL | 209335-001 | Dec 22, 2017 | AB | RX | No | No | ⤷ Start Trial | ⤷ Start Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Similar Applicant Names
Here is a list of applicants with similar names.

